An experienced neurotech team

Christian Angermayer is an entrepreneur, investor, and film enthusiast. He is the founder of Apeiron Investment Group, his family office, and merchant banking business. Apeiron focuses on investments in biotech, fintech & crypto, and deep tech companies. Apeiron completes deals across the entire lifecycle and balance sheet of a company, from non-listed seed/start-up investments to larger-scale restructuring and special situations deals. Passionate about the arts and film, Christian has (executive) produced 21 feature films including critically acclaimed movies like Filth, Aspern Papers and Hector and the Search for Happiness. He is the largest shareholder of DEAG, one of the largest live entertainment companies in Europe. Christian has a unique art collection centered around the theme “Psychedelics / Entheogens”. With his biotech company ATAI Life Sciences, Christian has the ambitious goal to find cures for various mental health issues like depression, anxiety, addiction, and PTSD by bringing back so-called psychedelics like “magic mushrooms” and DMT into the legal realm as powerful medical treatment. In addition to his entrepreneurial activities, Christian places great value on social, political, and societal commitments. He is a Young Global Leader of the World Economic Forum, a member of the Presidential Advisory Council of His Excellency President Paul Kagame of Rwanda, and a member of the Milken Institute Young Leaders Circle. Christian’s “Angermayer Policy and Innovation Forum” convenes several times a year Head of States, leading politicians, artists, investors, and scientists to discuss crucial topics and issues.

Dr. Tim Sievers is an entrepreneur and investor. He founded the FinTech pioneer Deposit Solutions in 2011. By the time he left his role as CEO 10 years later, the company was working with over 400 banks in 25 countries with more than 25bn USD in AuM and had achieved a “unicorn” valuation. Before founding Deposit Solutions, Tim was trained as an economist at the universities of Oxford, LSE, Toulouse, and Hamburg, and has worked as an investor in private equity. He serves as a Member of the Board at Adraxe and Blackrock Neurotech.

Dr. Solzbacher is co-founder and Chairman of Blackrock Neurotech. He is also a Professor and Chair of the Department of Electrical and Computer Engineering and Director of the Center for Engineering Innovation at the University of Utah. Florian holds adjunct appointments as a Professor in Materials Science and Professor of Biomedical Engineering at the University of Utah. He is a fellow of the American Institute for Medical and Biological Engineers AIMBE and a fellow of the Institute of Electrical and Electronics Engineers IEEE. Prof. Solzbacher received his M.Sc. EE (Dipl.-Ing.) from the Technical University Berlin in 1997 and his Ph.D. (Dr.-Ing.) from the Technical University Ilmenau in 2003. He is co-founder of several companies, including Blackrock Microsystems, Blackrock Neuromed, Blackrock Microsystems Europe, Sentiomed, First Sensor Technology, and several others. He was a board member and Chairman of the German Association for Sensor Technology AMA and of Sensor + Test from 2001 until 2009. Florian was director of the Utah Nanofabrication Laboratory until 2013 and served on a number of company and public/private partnership advisory and reviewer boards in Europe and the US including the DFG German Excellence Initiative, the European Research Council ERC, The Utah Governor’s Science and Technology advisory board and on international conference steering committees such as the NIH/NINDS Neural Interfaces Conference. He was Co-Chair of the 2012 NIH Neural Interfaces Conference and the 2014 COMS Conference for Commercialization of Micro and Nanosystems. He is the author of over 190 journal and conference publications, 5 book chapters, and 16 pending patents.

Marcus is CEO of Blackrock Neurotech. He is on the advisory board of various disruptive technology companies including fin-tech Deposit Solutions (US). Marcus has an MPhil from Oxford University and an MA from St. Andrews. He is an entrepreneur focused on innovative technologies and alternative investment markets. In 1999, Marcus helped set up his first start-up, Mondus, a pioneering e-commerce platform. Subsequently, Marcus founded BBI, which advised technology companies on funding, commercialization, and growth strategies. In 2003, he co-founded one of the leading frontier market asset managers in the Middle East. With Blackrock, he is hoping to improve the patient impact as it relates to the final frontier of the human body – the brain. He is all too aware of the limits of his own body when it comes to riding and hiking up and down the Wasatch mountains, but that does not stop him from trying to push that frontier too.

Rob earned his Ph.D. from the University of Michigan in Ann Arbor where he developed electrodes for in vivo neurotransmitter sensing. Following his Ph.D. studies, Rob began his work at Blackrock Neurotech where he has directed a team of engineers in the design and development of implantable, wireless neural interface electronics and novel silicon electrodes for recording and stimulation in the brain. His deep technical understanding and solution-oriented engineering approach have put him at the core of our clinical translation activities. Rob’s enthusiasm and commitment know no bounds, whether it is showing his support for the environment by braving US highways with an electric vehicle or his team spirit by playing soccer when really he would prefer football tackling us all.

Raj received his Ph.D. degree in Electrical and Computer Engineering from the University of Utah and an MTech degree in solid-state materials from the Indian Institute of Technology. He is currently Director of Clinical Translation Electrodes in Blackrock Neurotech and Adjunct Assistant Professor in Electrical and Computer Engineering at the University of Utah. He has been involved in prototyping and manufacturing various microfabrication, neural interface technologies, and devices. Raj is the author of several scientific and engineering publications and has three patents and several others pending in the USPTO. Raj is a specialist in implantable devices and systems, MEMS, and grants. He has introduced the Blackrock team to the merits of Indian food and tea.

Kristen completed her undergraduate degree in Biomedical Engineering at the University of Utah where she researched the optimization of hyaluronic acid-based hydrogels for applications in tissue engineering. Following her undergraduate studies, Kristen began work at Blackrock Neurotech within the R&D department and has since risen up the ranks to take on the position of VP of Business Operations. Her work focuses on maximizing efficiency and productivity while maintaining Blackrock’s highest quality standards. No matter how pressing, no matter how tall the task, no matter how unreasonable the ask, Kristen somehow manages to stay calm and navigate matters to success. When not hard at work, you’ll find her playing tennis, chasing after her 3 kids, or relaxing with a good book.

Shehan joined Blackrock Neurotech in 2017 and has more than 15 years of experience in accounting, financial analysis, treasury management, grant and governmental finance, and commercial & retail banking. Before being named VP of Finance, Shehan served Blackrock in a variety of roles of increasing importance, including Senior Accountant and Finance Manager. He began his career at banking giant HSBC in Colombo, Sri Lanka, and moved to the United States to peruse a degree in Finance at the University of Utah. Outside of his duties at Blackrock Neurotech, Shehan served in financial / management consulting roles at several nonprofits in Utah and Sri Lanka, including the Utah Pride Center.

Sandeep is the Director of Research Electrodes. Sandeep received his master’s degree in physics from IIT-Delhi and Ph.D. from the University of Utah. He has been PD/PI in several federal and state-funded grants. He is the author of over 50 journal and conference publications, book chapters, and 10+ pending patents. He has 21 years of experience in microfabrication and testing of semiconductor and MEMS implantable devices. While his expertise in microdevices and bio-materials is unquestionable, his talents extend to football (soccer) and teaching the staff cricket (a tall order when considering it is played for five days without necessarily identifying a winner).

Sherman has over 17 years of experience in the neuroscience research field. He earned degrees in physics and mathematics from the University of Saskatchewan in Canada, followed by a Ph.D. in Neuroscience from New York University where he studied the role of the hippocampus in olfactory memory in freely-behaving rodents. He also holds an MBA from Southern Methodist University. Sherman held multiple positions at Plexon Inc, first as sales manager, then as director of worldwide sales and marketing, and finally as Managing Director of Plexon Europe. Subsequently, Sherman founded NeuronautX, a scientific consultancy firm based in Brussels. Since 2016, Sherman is a key advisor for Blackrock Neurotech in Europe. Sherman’s clearest thinking occurs during the long runs which have already led him to four completed marathons in the last years. Not even the fact that he is based in Brussels, the capital of beer and fine chocolates, could keep him from this achievement.

Jeff Tsang spent 18 years in the Bay State before deciding he needed a change in scenery. He completed his B.S. in bioengineering at Rice University in Houston and briefly worked at Epic Systems in Wisconsin before deciding to return to Boston and attend Boston University for an M.S. in biomedical engineering. During his time at BU, he fostered an interest in electrophysiology in Dr. Laura Lewis’s lab working on utilizing wire loop motion sensors for artifact reduction in simultaneous EEG-fMRI. He uses his experience in technical services and ephys at Blackrock Neurotech as a member of the Support team. When he’s not troubleshooting ephys systems, he can be found eating a kickin’ a capoeira roda or scratching the 8-ball in a pool game.